Genmab — Juni 2019

Sukkeralf

Ja for at få 150 millioner dollars - det er jo en odds 10 kupon

Sukkeralf

Dog en gammel tommelfingerregel

Parasitism

God morgen

E_L

@ 08:03 if it is meant as a replacement for Dara, that is logical, as Dara will be at 20%; it wouldnt makes sense for Genmab to offer a replacement at lower royalties

E_L

What has been bothering me since yesterday, is that after 2031 both Dara and HexaBody-CD38 will each separately have tiered royalties, the way i read it

E_L

In other words, if the HexaBody-CD38 also starts 20% from $3bn, now the first $6bn of the sum of Dara and HexaBody-CD38 will be below 20%.

E_L

not sure if i am writing this very clearly here lol, but you know what i mean i hope

Sukkeralf

You could be right about that - but it will only be a few years before Darzalex run out of patent protection and then maybe Janssen will put all effords on Hexa-CD38

Sukkeralf

Thats probably also why Genmab could negotiate the 20% until 2031

E_L

yes, could be, i was thinking similarly. But surely they will keep selling some Dara for years to come, even if off-patent. (I could not exactly place 2031 btw, it is after IV patent and before SC patent?)

Sukkeralf

But its kind of a luxury with sc Darzalex, Hexa-CD38, BCMA/CD3 and GPCR5D/CD3 - all with different royalties but a hope for some earnings in MM for a very long time

Sukkeralf

Its more or less impossible to know how the competitive landscape look 10 years from now - we just know that we will still have a good earnings at that time also

E_L

yes, if it works, yesterdays deal could be a huge strategic step forward. very exciting.

Sukkeralf

Lets hope it was a new beginning for HexaBody..........and more promise for HexElect !

Bella1

Har en fornemmelse af at Gen vil skille sig positivt ud på denne lyserøde dag

JKY_VH

dine fornemmelser har vel en succesrate på 50% løselig husket:-)

JKY_VH

altså enten skiller den sig ud eller også gør den ikke:-)

bibob

Bella1

Man skal vel ikke kimse af 50%?

bibob

Absolut ikke.